Technology
Withings introduces AI audio analysis for BeamO heart and lung records
The subscription feature uses third-party algorithms to analyze recorded sounds beginning in October.
The short version
- At IFA 2026, Withings unveiled StethO Sense, an AI tool for its BeamO device launching October 1.[CNET]
- The service utilizes eMurmur to screen for heart murmurs and StethoMe to analyze breathing patterns.[CNET]
- Users must subscribe to Withings+ for $10 monthly or $100 annually to access the analyses, which are not formal medical diagnoses.[CNET]
- StethoMe is restricted to general tracking and is not intended for individuals with diagnosed respiratory conditions.[CNET]
Key facts
- Withings announced StethO Sense at IFA 2026 to analyze BeamO recordings using eMurmur Heart AI and StethoMe.[CNET]
- Withings stated that the FDA-cleared eMurmur algorithm was evaluated in peer-reviewed clinical studies on adults and children.[CNET]
- StethoMe generates a Breathing Index score from 0 to 100 but is not meant for people diagnosed with conditions like asthma, bronchitis, or COPD.[CNET]
- The tool launches October 1 for Withings+ subscribers, priced at $10 monthly or $100 yearly, and its results do not constitute medical diagnoses.[CNET]
- Existing BeamO owners and new buyers of the $250 device receive a one-month free trial of Withings+.[CNET]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.